Frederick M. Hudson - 22 Feb 2024 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
22 Feb 2024
Transactions value $
$0
Form type
4
Filing time
26 Feb 2024, 17:01:19 UTC
Previous filing
17 Nov 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SUPN Common Stock 33,231 22 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Director Stock Option (Right to Buy) Award $0 +8,252 $0 8,252 22 Feb 2024 Common Stock 8,252 $27.94 Direct F1
transaction SUPN Restricted Stock Units Award $0 +5,369 $0 5,369 22 Feb 2024 Common Stock 5,369 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on February 22, 2025.
F2 Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F3 These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025.